SaiyanMedTirzepatide
Ordered Tirzepatide from SaiyanMed? Mail in a sample (US only) and let us test it for free.
Test my supplySaiyan Med's purity-focus record is a narrow Retatrutide file, with recent identity-passing tests showing strong 99.8–99.9% purity after an earlier purity miss. Evidence is current but limited to one rated peptide, and mixed batch documentation plus modest fill deviations keep the trend less settled than the rebound suggests.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including SaiyanMed rows.
Cancel anytime
About SaiyanMed test results from Finnrick
SaiyanMed is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 20 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible SaiyanMed peptides in this dataset are GHK-Cu (1 test), Retatrutide (13 tests) and Tesamorelin (2 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 20 recent tests.
Ordered Tirzepatide from SaiyanMed? Mail in a sample (US only) and let us test it for free.
Test my supply